Democratic Republic of Congo vs Laos: Immunization, Hib3 (% of children ages 12-23 months)
Democratic Republic of Congo
65.0%
in 2024
Laos
67.0%
in 2024
Democratic Republic of Congo rank
176th
Laos rank
174th
Immunization, Hib3 (% of children ages 12-23 months) over time
- Democratic Republic of Congo
- Laos
How they compare
Laos currently reports 67.0% against 65.0% in Democratic Republic of Congo, a difference of 2.0%.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Laos ahead.
Democratic Republic of Congo ranks 176th and Laos ranks 174th of 191 countries.
Laos has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Democratic Republic of Congo | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 70.0% | 77.6% | 7.6% | Laos |
| 2020s | 65.0% | 67.4% | 2.4% | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Democratic Republic of Congo or Laos?
- Laos, at 67.0% against 65.0% in Democratic Republic of Congo as of 2024.
- What is the difference in immunization, hib3 between Democratic Republic of Congo and Laos?
- 2.0%, with Laos ahead.
- How many years of comparable data are there for Democratic Republic of Congo and Laos?
- 15 years are reported by both, from 2010 to 2024.
- How do Democratic Republic of Congo and Laos rank globally for immunization, hib3?
- Democratic Republic of Congo ranks 176th and Laos ranks 174th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.